Research map: Glomerulus-Targeted Nanotherapy via Collagen IV-α3 Binding Enhances Renal Immunoregulation in Lupus Nephritis

Back to the article

Papers in this map

  1. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles · Frank Alexis · 2008 · 3686 citations · Cited by this paper
  2. Edaravone Dexborneol regulates the endothelial PPARγ-PON1 axis to inhibit high-cholesterol-induced atherosclerosis · 2026 · Related
  3. Strategies in the design of nanoparticles for therapeutic applications · Robby A. Petros · 2010 · 3648 citations · Cited by this paper
  4. Ex vivo pretreatment of donor organ with siRNA nanoparticles attenuates cold ischemia-reperfusion injury in cardiac transplantation · 2026 · Related
  5. Liposome: classification, preparation, and applications · Abolfazl Akbarzadeh · 2013 · 3645 citations · Cited by this paper
  6. O-GlcNAc modification of CaMKII-mediated mitophagic flux regulation via HSPB8 in diabetic cardiomyopathy · 2026 · Related
  7. Systemic lupus erythematosus · Arvind Kaul · 2016 · 1420 citations · Cited by this paper
  8. Antimicrobial and immune-modulating effects of recombinant pancreatitis-associated protein in the treatment of MRSA-induced severe septic arthritis · 2026 · Related
  9. Organ targeting In vivo using phage display peptide libraries · Renata Pasqualini · 1996 · 1233 citations · Cited by this paper
  10. ASGR1 induces neutrophil extracellular traps formation to exacerbate sepsis-induced myocardial injury and cardiac dysfunction through SLC7A11 ubiquitination · 2026 · Related
  11. Lupus nephritis · Hans‐Joachim Anders · 2020 · 972 citations · Cited by this paper
  12. The metabolic effects of post-sepsis feeding of meals with only essential amino acids · 2026 · Related
  13. Update on Lupus Nephritis · Salem J. Almaani · 2016 · 953 citations · Cited by this paper
  14. Unravelling the effects of selective estrogen receptor modulators on colorectal cancer: a prognostic role for insulin-like growth factor binding protein-5 · 2026 · Related
  15. Physico-chemical stability of colloidal lipid particles · B Heurtault · 2003 · 837 citations · Cited by this paper
  16. Human cytomegalovirus at the maternal–fetal interface: an overview of pathogenesis, defence, and interventions · 2026 · Related
  17. Update on Lupus Nephritis: Core Curriculum 2020 · Samir V. Parikh · 2020 · 524 citations · Cited by this paper
  18. The regulation of intrahepatic fatty acid partitioning within the human liver: the effect of sex · 2026 · Related
  19. The Pathogenesis of Lupus Nephritis · Maciej Lech · 2013 · 512 citations · Cited by this paper
  20. The unfolded protein response and its activation by insulin in muscle are not altered by obesity or type 2 diabetes · 2026 · Related
  21. Targeting kidney mesangium by nanoparticles of defined size · Chung Hang Jonathan Choi · 2011 · 503 citations · Cited by this paper
  22. RETRACTED: Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol · Pooria Nakhaei · 2021 · 482 citations · Cited by this paper
  23. Cancer drug delivery in the nano era: An overview and perspectives · Zhen Li · 2017 · 413 citations · Cited by this paper
  24. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis · Chandra Mohan · 2015 · 381 citations · Cited by this paper
  25. Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane · Jonathan E. Zuckerman · 2012 · 376 citations · Cited by this paper
  26. Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. · Raghu K. Kalluri · 1997 · 323 citations · Cited by this paper
  27. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo · Mingming Zhang · 2021 · 275 citations · Cited by this paper
  28. Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man · Verena Raker · 2015 · 263 citations · Cited by this paper
  29. Nanomedicines for renal disease: current status and future applications · Nazila Kamaly · 2016 · 254 citations · Cited by this paper
  30. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics · Xiaofeng Dai · 2025 · 218 citations · Cited by this paper
  31. Tertiary Lymphoid Structures: Autoimmunity Goes Local · Elena Pipi · 2018 · 192 citations · Cited by this paper
  32. Markedly Different Pathogenicity of Four Immunoglobulin G Isotype-Switch Variants of an Antierythrocyte Autoantibody Is Based on Their Capacity to Interact in Vivo with the Low-Affinity Fcγ Receptor III · Liliane Fossati‐Jimack · 2000 · 181 citations · Cited by this paper
  33. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration · Fleur M. van der Valk · 2015 · 170 citations · Cited by this paper
  34. A chitosan-modified graphene nanogel for noninvasive controlled drug release · Chunyan Wang · 2013 · 148 citations · Cited by this paper
  35. A Small-Molecule Macrophage Migration Inhibitory Factor Antagonist Protects against Glomerulonephritis in Lupus-Prone NZB/NZW F1 and MRL/ lpr Mice · Lin Leng · 2010 · 137 citations · Cited by this paper
  36. Mechanisms of Tissue Injury in Lupus Nephritis · Giovanna Flores-Mendoza · 2018 · 130 citations · Cited by this paper
  37. Low-dose interleukin-2 therapy in active systemic lupus erythematosus (LUPIL-2): a multicentre, double-blind, randomised and placebo-controlled phase II trial · Jens Y. Humrich · 2022 · 124 citations · Cited by this paper
  38. MRI of the basement membrane using charged nanoparticles as contrast agents · Kevin M. Bennett · 2008 · 113 citations · Cited by this paper
  39. IL233, A Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury · Marta E. Stremska · 2017 · 105 citations · Cited by this paper

Source: OpenAlex (CC0)